chr7-151013712-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000603.5(NOS3):c.3256-12G>A variant causes a splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0143 in 1,157,552 control chromosomes in the GnomAD database, including 1,400 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.054 ( 738 hom., cov: 33)
Exomes 𝑓: 0.0083 ( 662 hom. )
Consequence
NOS3
NM_000603.5 splice_polypyrimidine_tract, intron
NM_000603.5 splice_polypyrimidine_tract, intron
Scores
2
Splicing: ADA: 0.00005298
2
Clinical Significance
Conservation
PhyloP100: -0.327
Genes affected
NOS3 (HGNC:7876): (nitric oxide synthase 3) Nitric oxide is a reactive free radical which acts as a biologic mediator in several processes, including neurotransmission and antimicrobial and antitumoral activities. Nitric oxide is synthesized from L-arginine by nitric oxide synthases. Variations in this gene are associated with susceptibility to coronary spasm. Alternative splicing and the use of alternative promoters results in multiple transcript variants. [provided by RefSeq, Oct 2016]
ATG9B (HGNC:21899): (autophagy related 9B) This gene functions in the regulation of autophagy, a lysosomal degradation pathway. This gene also functions as an antisense transcript in the posttranscriptional regulation of the endothelial nitric oxide synthase 3 gene, which has 3' overlap with this gene on the opposite strand. Mutations in this gene and disruption of the autophagy process have been associated with multiple cancers. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 7-151013712-G-A is Benign according to our data. Variant chr7-151013712-G-A is described in ClinVar as [Benign]. Clinvar id is 1279688.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.182 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NOS3 | NM_000603.5 | c.3256-12G>A | splice_polypyrimidine_tract_variant, intron_variant | ENST00000297494.8 | |||
ATG9B | NR_073169.1 | n.2640+18C>T | intron_variant, non_coding_transcript_variant | ||||
ATG9B | NR_133652.1 | n.3377+18C>T | intron_variant, non_coding_transcript_variant | ||||
ATG9B | XR_007060009.1 | n.3420+18C>T | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NOS3 | ENST00000297494.8 | c.3256-12G>A | splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_000603.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0540 AC: 8124AN: 150354Hom.: 738 Cov.: 33
GnomAD3 genomes
AF:
AC:
8124
AN:
150354
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0139 AC: 2662AN: 191984Hom.: 212 AF XY: 0.0101 AC XY: 1061AN XY: 104968
GnomAD3 exomes
AF:
AC:
2662
AN:
191984
Hom.:
AF XY:
AC XY:
1061
AN XY:
104968
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00832 AC: 8379AN: 1007082Hom.: 662 Cov.: 31 AF XY: 0.00711 AC XY: 3608AN XY: 507716
GnomAD4 exome
AF:
AC:
8379
AN:
1007082
Hom.:
Cov.:
31
AF XY:
AC XY:
3608
AN XY:
507716
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0540 AC: 8131AN: 150470Hom.: 738 Cov.: 33 AF XY: 0.0521 AC XY: 3830AN XY: 73540
GnomAD4 genome
AF:
AC:
8131
AN:
150470
Hom.:
Cov.:
33
AF XY:
AC XY:
3830
AN XY:
73540
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
38
AN:
3474
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 05, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at